NASDAQ:INCY

Incyte Stock Insider Trading

Healthcare > Biotechnology

Buy INCY

*Your capital is at risk

$97.98

+5.74 (+6.22%)

At Close: Jun 03, 2026

Incyte Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -62.84. In total, the insiders bought 754.56K and sold 443.84K INCY shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-62.84
● Buy	754.56K shares
● Sell	443.84K shares
65% Buy Activity Strong Positive Correlation
Buy Signal Low Confidence May 06, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -62.84. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 01, 2025 Sell	Common Stock F-InKind	Stein Steven H EVP & Chief Medical Officer	Officer	17 093 Value: $1.74M
Dec 01, 2025 Sell	Common Stock F-InKind	Morrissey Michael James EVP, Head Of Tech. Operations	Officer	326 Value: $33.3K
Dec 01, 2025 Buy	Performance Shares A-Award	Hoffman Richard A. EVP & General Counsel	Officer	23 665 Value: $2.41M
Dec 01, 2025 Buy	Common Stock J-Other	Hoffman Richard A. Officer	Officer	0 Value: $0
Nov 24, 2025 Sell	Common Stock S-Sale	Tray Thomas Principal Accounting Officer	Officer	600 Value: $61.8K
Nov 21, 2025 Sell	Common Stock S-Sale	Tray Thomas Principal Accounting Officer	Officer	169 Value: $17.2K
Nov 17, 2025 Buy	Employee Stock Option (right to buy) M-Exempt	Denton Sheila A. EVP & General Counsel	Officer	278 Value: $17.9K
Nov 17, 2025 Buy	Common Stock M-Exempt	Denton Sheila A. EVP & General Counsel	Officer	278 Value: $17.9K
Nov 17, 2025 Sell	Common Stock S-Sale	Denton Sheila A. EVP & General Counsel	Officer	278 Value: $29.0K
Nov 10, 2025 Sell	Common Stock S-Sale	Hoppenot Herve Director	Director	187 500 Value: $19.8M
Nov 05, 2025 Buy	Incentive Stock Option (right to buy) M-Exempt	Stein Steven H EVP & Chief Medical Officer	Officer	1 044 Value: $100.0K
Nov 05, 2025 Buy	Non-Qualified Stock Option (right to buy) M-Exempt	Stein Steven H EVP & Chief Medical Officer	Officer	1 194 Value: $100.1K
Nov 05, 2025 Buy	Common Stock M-Exempt	Stein Steven H EVP & Chief Medical Officer	Officer	1 044 Value: $100.0K
Nov 05, 2025 Buy	Common Stock M-Exempt	Stein Steven H EVP & Chief Medical Officer	Officer	2 995 Value: $286.8K
Nov 05, 2025 Buy	Common Stock M-Exempt	Stein Steven H EVP & Chief Medical Officer	Officer	1 194 Value: $100.1K
Nov 05, 2025 Sell	Common Stock S-Sale	Stein Steven H EVP & Chief Medical Officer	Officer	5 233 Value: $534.8K
Nov 05, 2025 Buy	Non-Qualified Stock Option (right to buy) M-Exempt	Stein Steven H EVP & Chief Medical Officer	Officer	2 995 Value: $286.8K
Nov 04, 2025 Buy	Common Stock M-Exempt	Denton Sheila A. EVP & General Counsel	Officer	598 Value: $34.7K
Nov 04, 2025 Sell	Common Stock S-Sale	Denton Sheila A. EVP & General Counsel	Officer	598 Value: $60.6K
Nov 04, 2025 Buy	Employee Stock Option (right to buy) M-Exempt	Denton Sheila A. EVP & General Counsel	Officer	598 Value: $34.7K
Nov 03, 2025 Sell	Common Stock S-Sale	Heeson Lee EVP, Head Of Incyte Intl	Officer	3 074 Value: $289.0K
Oct 15, 2025 Buy	Employee Stock Option (right to buy) M-Exempt	Denton Sheila A. EVP & General Counsel	Officer	277 Value: $17.8K
Oct 15, 2025 Sell	Common Stock S-Sale	Denton Sheila A. EVP & General Counsel	Officer	277 Value: $23.6K
Oct 15, 2025 Buy	Common Stock M-Exempt	Denton Sheila A. EVP & General Counsel	Officer	277 Value: $17.8K
Oct 02, 2025 Buy	Common Stock M-Exempt	Denton Sheila A. EVP & General Counsel	Officer	599 Value: $34.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT INCYTE CORPORATION

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr...

Read Full Profile Here